🇺🇸 FDA
Patent

US 12228582

Method and apparatus for testing near infrared-photoimmunotherapy treatment

granted A61KA61K2039/505A61K41/0042

Quick answer

US patent 12228582 (Method and apparatus for testing near infrared-photoimmunotherapy treatment) held by The United States of America as Represented By The Secretary of the Department of Health and Human expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented By The Secretary of the Department of Health and Human
Grant date
Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/505, A61K41/0042, A61K41/0071, A61K47/6849